MYELOFIBROSIS (MF)

Clinical trials for MYELOFIBROSIS (MF) explained in plain language.

Never miss a new study

Get alerted when new MYELOFIBROSIS (MF) trials appear

Sign up with your email to follow new studies for MYELOFIBROSIS (MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 6 Not yet finished but already full! 1 Completed 3

New hope for myelofibrosis patients: drug combo targets enlarged spleen

Disease control Ongoing

This study tests whether adding the experimental drug navitoclax to standard therapy ruxolitinib can shrink the spleen and ease symptoms in adults with myelofibrosis, a rare bone marrow cancer. About 330 participants whose cancer returned or didn't improve after prior treatment w…

Matched conditions: MYELOFIBROSIS (MF)

Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

MYELOFIBROSIS (MF)

Get alerted when new MYELOFIBROSIS (MF) trials appear

New hope for myelofibrosis patients: drug combo targets enlarged spleen